Metaxalone Tablet
Product Images NDC 82804-323

3 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metaxalone (NDC 82804-323). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Metaxalone 800 mg (Chemical Structure)

Metaxalone 800 mg (Chemical Structure)
Chemical structure of Metaxalone. The diagram shows a benzene ring substituted with two methyl groups, connected via an oxygen atom to a side chain containing an oxazolidinone ring. This molecular structure represents the active ingredient Metaxalone.*
FDA Label Image

Figure 1 (Mean (SD) Concentrations of Metaxalone following an 800 mg Dose under Fasted and Fed Conditions.)

Figure 1 (Mean (SD) Concentrations of Metaxalone following an 800 mg Dose under Fasted and Fed Conditions.)
A line graph illustrating the mean (standard deviation) concentrations of Metaxalone in ng/mL over 12 hours following an 800 mg oral dose under fasted and fed conditions. The x-axis represents time in hours, and the y-axis shows Metaxalone concentration. Two curves depict concentration profiles for fasted and fed states, with concentrations generally higher and peaking later under fed conditions.*
FDA Label Image

82804-323-60 (Image 01)

82804-323-60 (Image 01)
Metaxalone 800 mg tablets packaging label containing 60 tablets. The label indicates each tablet contains 800 mg of metaxalone, USP. Tablets are described as pink, capsule-shaped scored with 'SG' on one side and '323' on the other. Packaged by Proficient Rx LP, with storage instructions at 20°-25°C (68°-77°F). Includes product ID ZM032360 and manufacturer ScieGen Pharmaceuticals, Inc., Hauppauge, NY.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.